Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

SUNEEL B KATRAGADDA

Allopathic & Osteopathic Physicians Psychiatry & Neurology Child & Adolescent Psychiatry

NPI
1972632388
CMS profile
180204
Location
ATLANTA, GA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$138,909.77

164 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

By paying entity

PY2024 · entire year · sorted by reported total

Page 3 of 4; records 101–150 of 164 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

SUNEEL B KATRAGADDA

NPI 1972632388 · CMS profile ID 180204

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Child & Adolescent Psychiatry

ATLANTA, GA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 4; records 101–150 of 164 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1972632388?year=2024&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
SUNEEL B KATRAGADDA, NPI 1972632388, CMS profile ID 180204. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 164 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1972632388?year=2024&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). SUNEEL B KATRAGADDA, NPI 1972632388, CMS profile ID 180204. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 164 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1972632388?year=2024&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
SUNEEL B KATRAGADDA, NPI 1972632388, CMS profile ID 180204, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 4; records 101–150 of 164 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1972632388?year=2024&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

164 matching records · $138,909.77 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 164 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 164.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Teva Pharmaceuticals USA, Inc. $7.2305/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1151626524 CMS
Otsuka America Pharmaceutical, Inc. $781.3105/08/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1118919402 CMS
Otsuka America Pharmaceutical, Inc. $2,546.0005/08/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1118919404 CMS
Otsuka America Pharmaceutical, Inc. $351.0005/08/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1118919406 CMS
Teva Pharmaceuticals USA, Inc. $31.4005/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1151626522 CMS
Otsuka America Pharmaceutical, Inc. $124.1005/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1118919400 CMS
Teva Pharmaceuticals USA, Inc. $18.7904/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1151626502 CMS
ABBVIE INC. $13.5404/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104038854 CMS
Axsome Therapeutics, Inc. $93.8904/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1148323333 CMS
Axsome Therapeutics, Inc. $2,250.0004/25/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1148323335 CMS
Janssen Pharmaceuticals, Inc $31.2504/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1077987808 CMS
Corium, LLC $22.8204/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1100088884 CMS
ABBVIE INC. $123.0304/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104038852 CMS
Lundbeck LLC $15.7604/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145931909 CMS
Lundbeck LLC $14.5904/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145931907 CMS
Neurocrine Biosciences, Inc. $6,587.5004/04/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150807145 CMS
Supernus Pharmaceuticals, Inc. $24.3204/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1147780138 CMS
ABBVIE INC. $27.6204/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104038850 CMS
Otsuka America Pharmaceutical, Inc. $1,742.0003/29/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1118919398 CMS
Neurocrine Biosciences, Inc. $68.3303/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150813258 CMS
Neurocrine Biosciences, Inc. $45.5703/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150814254 CMS
Neurocrine Biosciences, Inc. $45.5703/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150814386 CMS
Neurocrine Biosciences, Inc. $476.2003/23/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150815456 CMS
Neurocrine Biosciences, Inc. $303.9703/23/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150828088 CMS
Neurocrine Biosciences, Inc. $23.6103/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150844416 CMS
Neurocrine Biosciences, Inc. $22.6903/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150847717 CMS
Neurocrine Biosciences, Inc. $119.4503/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150810438 CMS
Neurocrine Biosciences, Inc. $41.4903/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150814732 CMS
ABBVIE INC. $28.2803/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104038848 CMS
Otsuka America Pharmaceutical, Inc. $124.9803/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1118919396 CMS
Axsome Therapeutics, Inc. $25.0003/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1148323315 CMS
Axsome Therapeutics, Inc. $503.2003/16/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1148323317 CMS
Axsome Therapeutics, Inc. $315.2703/16/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1148323319 CMS
Axsome Therapeutics, Inc. $166.0003/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1148323321 CMS
Axsome Therapeutics, Inc. $8,500.0003/16/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1148323323 CMS
Axsome Therapeutics, Inc. $24.5503/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1148323325 CMS
Axsome Therapeutics, Inc. $75.0003/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1148323327 CMS
Axsome Therapeutics, Inc. $24.5503/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1148323329 CMS
Axsome Therapeutics, Inc. $35.0003/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1148323331 CMS
Otsuka America Pharmaceutical, Inc. $175.5003/15/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1118919394 CMS
Janssen Pharmaceuticals, Inc $4,800.0003/08/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1077987544 CMS
ABBVIE INC. $17.9103/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104038846 CMS
Otsuka America Pharmaceutical, Inc. $1,742.0003/01/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1118919392 CMS
Janssen Pharmaceuticals, Inc $54.5102/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1077986772 CMS
Janssen Pharmaceuticals, Inc $15.5802/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1077987138 CMS
Janssen Pharmaceuticals, Inc $18.1802/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1077987174 CMS
Janssen Pharmaceuticals, Inc $36.3602/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1077987416 CMS
Janssen Pharmaceuticals, Inc $33.0702/23/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1077986746 CMS
Janssen Pharmaceuticals, Inc $16.2102/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1077986814 CMS
Janssen Pharmaceuticals, Inc $13.5202/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1077986944 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $10,527.09 124
PY2020 $5,585.40 27
PY2021 $19,792.02 96
PY2022 $47,341.88 88
PY2023 $71,331.88 159
PY2024 $138,909.77 164
PY2025 $166,401.78 177

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $43,548.88 20
PY2024 Recipient $309.65 5
PY2024 Principal investigator $117,604.50 34
PY2023 Principal investigator $94,788.67 84
PY2022 Principal investigator $281,459.70 62
PY2021 Principal investigator $470,725.44 85
PY2020 Recipient $1,246.49 7
PY2020 Principal investigator $354,088.62 57
PY2019 Principal investigator $240,206.73 57

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

20 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ABBVIE INC. $708.20 12/31/2025 Non-covered Recipient Entity
ATLANTA BEHAVIORAL RESEARCH LLC
A 52-Week, Multicenter, Open-Label, Flexible-dose Study to Evaluate the Long-term Safety and Tolerability of Cariprazine in the Treatment of Pediatric Subjects with Schizophrenia, Bipolar I Disorder, or Autism Spectrum Disorder No dispute reported 06/30/2026 1202534031
Principal investigator 1 ABBVIE INC. $1,099.68 12/31/2025 Non-covered Recipient Entity
ATLANTA BEHAVIORAL RESEARCH LLC
A 6-week, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study of the Efficacy and Safety of Cariprazine in Pediatric Subjects (10 to 17 years of age) in the Treatment of Depressive Episodes Associated with Bipolar I Disorder No dispute reported 06/30/2026 1202534045
Principal investigator 1 Janssen Research & Development, LLC $1,581.00 11/12/2025 Non-covered Recipient Entity
Atlanta Bhvrl Medcn
A Study in Participants With Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI) (VENTURA-RWE) No dispute reported 06/30/2026 1175205282
Principal investigator 1 Janssen Research & Development, LLC $1,581.00 10/06/2025 Non-covered Recipient Entity
Atlanta Bhvrl Medcn
A Study in Participants With Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI) (VENTURA-RWE) No dispute reported 06/30/2026 1175206482
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,742.00 10/02/2025 Non-covered Recipient Entity
ATLANTA BEHAVIORAL RESEARCH LLC
ITI-007-321 No dispute reported 06/30/2026 1242360408
Principal investigator 1 Janssen Research & Development, LLC $350.00 10/02/2025 Non-covered Recipient Entity
Atlanta Bhvrl Medcn
A Study in Participants With Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI) (VENTURA-RWE) No dispute reported 06/30/2026 1175204209
Principal investigator 1 Janssen Research & Development, LLC $1,092.00 08/06/2025 Non-covered Recipient Entity
Atlanta Bhvrl Medcn
A Study in Participants With Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI) (VENTURA-RWE) No dispute reported 06/30/2026 1175205983
Principal investigator 1 Janssen Research & Development, LLC $2,358.00 07/09/2025 Non-covered Recipient Entity
Atlanta Bhvrl Medcn
A Study in Participants With Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI) (VENTURA-RWE) No dispute reported 06/30/2026 1175207156
Principal investigator 1 Janssen Research & Development, LLC $5,700.00 06/30/2025 Non-covered Recipient Entity
ATLANTA BEHAVIORAL RESEARCH LLC
A Two-Part Multicenter, Double-Blind, Randomized Placebo-Controlled Study to Evaluate Efficacy and Safety and the Maintenance of Effect of 20-mg Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Patients with Major Depressive Diso No dispute reported 06/30/2026 1175375686
Principal investigator 1 ABBVIE INC. $1,200.00 06/20/2025 Non-covered Recipient Entity
ATLANTA BEHAVIORAL RESEARCH LLC
Open-Label Flexible-dose Study to Evaluate the Long-Term Safety and Tolerability of Cariprazine in the Treatment of Pediatric Participants With Schizophrenia or Bipolar I Disorder No dispute reported 06/30/2026 1202492563
Principal investigator 1 Janssen Research & Development, LLC $144.00 05/19/2025 Non-covered Recipient Entity
Atlanta Bhvrl Medcn
A Study in Participants With Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI) (VENTURA-RWE) No dispute reported 06/30/2026 1175206152
Principal investigator 1 Janssen Research & Development, LLC $1,581.00 05/07/2025 Non-covered Recipient Entity
Atlanta Bhvrl Medcn
A Study in Participants With Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI) (VENTURA-RWE) No dispute reported 06/30/2026 1175207010
Principal investigator 1 Janssen Research & Development, LLC $6,155.00 04/09/2025 Non-covered Recipient Entity
Atlanta Bhvrl Medcn
A Study in Participants With Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI) (VENTURA-RWE) No dispute reported 06/30/2026 1175206236
Principal investigator 1 Janssen Research & Development, LLC $4,425.00 03/24/2025 Non-covered Recipient Entity
ATLANTA BEHAVIORAL RESEARCH LLC
A Two-Part Multicenter, Double-Blind, Randomized Placebo-Controlled Study to Evaluate Efficacy and Safety and the Maintenance of Effect of 20-mg Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Patients with Major Depressive Diso No dispute reported 06/30/2026 1175375694
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $1,500.00 03/17/2025 Non-covered Recipient Entity
ATLANTA BEHAVIORAL RESEARCH LLC
ITI-007-321 No dispute reported 06/30/2026 1242338073
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $1,900.00 03/17/2025 Non-covered Recipient Entity
ATLANTA BEHAVIORAL RESEARCH LLC
ITI-007-321 No dispute reported 06/30/2026 1242338075
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $1,000.00 03/17/2025 Non-covered Recipient Entity
ATLANTA BEHAVIORAL RESEARCH LLC
ITI-007-321 No dispute reported 06/30/2026 1242338077
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $1,000.00 03/17/2025 Non-covered Recipient Entity
ATLANTA BEHAVIORAL RESEARCH LLC
ITI-007-321 No dispute reported 06/30/2026 1242338079
Principal investigator 1 Janssen Research & Development, LLC $4,882.00 03/12/2025 Non-covered Recipient Entity
Atlanta Bhvrl Medcn
A Study in Participants With Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI) (VENTURA-RWE) No dispute reported 06/30/2026 1175205759
Principal investigator 1 ABBVIE INC. $550.00 01/28/2025 Non-covered Recipient Entity
ATLANTA BEHAVIORAL RESEARCH LLC
M21-465 - Study of Cariprazine Oral Capsules or Solution to Assess Adverse Events and Change in Irritability Due to Autism Spectrum Disorder (ASD) in Participants Aged 5-17 Years With ASD No dispute reported 06/30/2026 1202441672